[ad_1]
Travelers’s stock was set to resume their rally in early trading Friday after the insurer beat second-quarter profit expectations by a wide margin, even as revenue missed and catastrophe losses increased.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...